(Sharecast News) - Roche reported a solid rise in earnings in 2025 on Thursday, but struck a cautious note on the outlook, as currency headwinds and softer-than-expected sales of a key eye drug tempered an otherwise improving performance driven by newer medicines and recent clinical successes.
Adjusted operating profit rose 5%...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE